Cargando…

Delayed publication of clinical trials in cystic fibrosis()

BACKGROUND: When the publication of important trial data is delayed, or data are never published, this will prevent the proper practice of evidence based medicine through robust systematic reviews. Clinical trial registries allow researchers to interrogate the trial protocol and afford the opportuni...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hurley, M.N., Prayle, A.P., Smyth, A.R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2012
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3267039/ https://www.ncbi.nlm.nih.gov/pubmed/21889426 http://dx.doi.org/10.1016/j.jcf.2011.08.004

Ejemplares similares

Results of antibiotic susceptibility testing do not influence clinical outcome in children with cystic fibrosis()
por: Hurley, M.N., et al.
Publicado: (2012)

The pharmacokinetics and toxicity of morning vs. evening tobramycin dosing for pulmonary exacerbations of cystic fibrosis: A randomised comparison
por: Prayle, A.P., et al.
Publicado: (2016)

Side effects of aminoglycosides on the kidney, ear and balance in cystic fibrosis
por: Prayle, Andrew, et al.
Publicado: (2010)

Novel approaches to the treatment of Pseudomonas aeruginosa infections in cystic fibrosis
por: Hurley, Matthew N., et al.
Publicado: (2012)

Rate of improvement of CF life expectancy exceeds that of general population—Observational death registration study()()
por: Hurley, Matthew N., et al.
Publicado: (2014)

Airway inflammatory markers in individuals with cystic fibrosis and non-cystic fibrosis bronchiectasis
por: Bergin, David A, et al.
Publicado: (2013)

Staphylococcus aureus in cystic fibrosis: problem bug or an innocent bystander?
por: Hurley, Matthew N.
Publicado: (2018)

Longitudinal impact of demographic and clinical variables on health-related quality of life in cystic fibrosis
por: Abbott, Janice, et al.
Publicado: (2015)

Clinical profile, diagnostic delay, and genetic make-up of cystic fibrosis in Kashmir, India
por: Mir, Tasaduq Ahmad, et al.
Publicado: (2011)

Delayed neutrophil apoptosis enhances NET formation in cystic fibrosis
por: Gray, Robert D, et al.
Publicado: (2018)

Clinical Effectiveness of Elexacaftor/Tezacaftor/Ivacaftor in People with Cystic Fibrosis: A Clinical Trial
por: Nichols, David P., et al.
Publicado: (2021)

US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis
por: Floto, R Andres, et al.
Publicado: (2016)

Novel Outcome Measures for Clinical Trials in Cystic Fibrosis
por: Tiddens, Harm AWM, et al.
Publicado: (2015)

Disease-specific clinical trials networks: the example of cystic fibrosis
por: De Boeck, Kris, et al.
Publicado: (2016)

US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis: executive summary
por: Floto, R Andres, et al.
Publicado: (2016)

A randomised controlled trial of rosuvastatin for the prevention of aminoglycoside-induced kidney toxicity in children with cystic fibrosis
por: McWilliam, Stephen J., et al.
Publicado: (2020)

Comparing cystic fibrosis outcomes across the pond
por: Taylor-Robinson, David C, et al.
Publicado: (2015)

Pseudomonas aeruginosa quorum sensing molecules correlate with clinical status in cystic fibrosis
por: Barr, Helen L., et al.
Publicado: (2015)

Future therapies for cystic fibrosis
por: Allen, Lucy, et al.
Publicado: (2023)

Physical activity for cystic fibrosis: perceptions of people with cystic fibrosis, parents and healthcare professionals
por: Denford, Sarah, et al.
Publicado: (2020)

Factors influencing physical activity in adults with cystic fibrosis
por: Hurley, Nicola, et al.
Publicado: (2021)

Author Correction: A randomised controlled trial of rosuvastatin for the prevention of aminoglycoside-induced kidney toxicity in children with cystic fibrosis
por: McWilliam, Stephen J., et al.
Publicado: (2020)

Evaluation of biofilm production by Pseudomonas Aeruginosa isolates recovered from cystic fibrosis and non-cystic fibrosis patients
por: Perez, L.R.R., et al.
Publicado: (2011)

Feasibility study to inform the design of a randomised controlled trial to eradicate Pseudomonas aeruginosa infection in individuals with Cystic Fibrosis
por: Hickey, Helen R, et al.
Publicado: (2010)

Clinical Advances in Cystic Fibrosis
por: Imperlini, Esther, et al.
Publicado: (2022)

Cystic Fibrosis
por: Dodge, J A
Publicado: (1997)

Decades of cough: delayed recognition of atypical cystic fibrosis in an adult patient
por: Chandel, Abhimanyu, et al.
Publicado: (2020)

Designing Clinical Trials for Anti-Inflammatory Therapies in Cystic Fibrosis
por: Perrem, Lucy, et al.
Publicado: (2020)

Cystic Fibrosis: Clinical Phenotypes in Children and Adolescents
por: dos Santos, Ana Luiza Melo, et al.
Publicado: (2018)

Sildenafil improves exercise capacity in patients with cystic fibrosis: a proof-of-concept clinical trial
por: Rodriguez-Miguelez, Paula, et al.
Publicado: (2019)

ePS1.04 Sleep disturbances in children with cystic fibrosis at the beginning and in the first year of the COVID-19 pandemic
por: Eyuboglu, T. Sismanlar, et al.
Publicado: (2022)

Allergic bronchopulmonary aspergillosis in patients with cystic fibrosis and non-cystic fibrosis bronchiectasis
por: Alyasin, Soheila, et al.
Publicado: (2018)

Cystic Fibrosis Transmembrane Conductance Regulator Genotype, Not Circulating Catecholamines, Influences Cardiovascular Function in Patients with Cystic Fibrosis
por: Bisch, Alexander L, et al.
Publicado: (2019)

A first-year dornase alfa treatment impact on clinical parameters of patients with cystic fibrosis: the Brazilian cystic fibrosis multicenter study
por: Rozov, Tatiana, et al.
Publicado: (2013)

Role of vitamin D in cystic fibrosis and non-cystic fibrosis bronchiectasis
por: Moustaki, Maria, et al.
Publicado: (2017)

The top 10 research priorities in cystic fibrosis developed by a partnership between people with CF and healthcare providers
por: Rowbotham, Nicola J, et al.
Publicado: (2018)

Measures of body habitus are associated with lung function in adults with cystic fibrosis: A population-based study()
por: Forrester, Doug L., et al.
Publicado: (2013)

Delayed release pancrelipase for the treatment of pancreatic exocrine insufficiency associated with cystic fibrosis
por: Baker, Susan S
Publicado: (2008)

Delayed HIV diagnosis in a cystic fibrosis patient: Not just another exacerbation
por: Bhatia, Sapna, et al.
Publicado: (2021)

A New Era for Cystic Fibrosis and Cystic Fibrosis Transmembrane Conductance Regulator Modulator Trials in Infants
por: Wainwright, Claire E.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_51jtdtt5u87te3d02hd50numrl